What is the expected growth forecast for the IVD market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers for the IVD And Laboratory Developed Tests market?

Increasing autoimmune disease prevalence and advances in diagnostic technologies drive the market.

Which regions are the leaders in the IVD And Laboratory Developed Tests market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the IVD And Laboratory Developed Tests For Autoimmune Diseases market?

Major players include Roche, Abbott, and Siemens Healthineers, among others.

What future opportunities exist in the IVD And Laboratory Developed Tests market?

Emerging markets and innovative technologies offer significant future outlook opportunities.

How does technology impact the IVD And Laboratory Developed Tests For Autoimmune Diseases market?

Advances in technologies like AI and genomics improve diagnostic accuracy and efficiency.

What is the current regulatory landscape for the IVD market?

Regulatory frameworks vary by region, with the FDA and EU's IVDR governing key markets.

How will the regulatory landscape evolve in the future?

Expected changes include increased emphasis on digital health and personalized medicine regulations.

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Growth Drivers & Forecast 2033

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases by Application (Diabetes, Infectious Diseases, Oncology or Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, HIV or Aids), by Types (Reagents and Kits, Instruments, Services, Data Management Software), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size | CAGR 10.2 Forecast 2033

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 85

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Overview

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market is a crucial segment of the healthcare industry, providing vital diagnostic solutions for autoimmune diseases. As the global prevalence of autoimmune diseases continues to rise, the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market size is estimated to be approximately $14.8 billion in 2025. The growth outlook for this market is promising, with a market forecast expecting significant expansion during the forecast period from 2026 to 2033, driven by advancements in diagnostic technologies and increasing demand for accurate and efficient testing solutions. The industry expansion is expected to be driven by key factors such as technology shifts, regulatory frameworks, and consumer behavior, with the global market projected to grow at a CAGR of 8.5%.

Loading chart…

The largest region in the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market is North America, driven by the presence of major market players and a well-established healthcare infrastructure. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing demand for diagnostic solutions and government initiatives to improve healthcare access. Key forces shaping the industry include competitive intensity, supply-chain dynamics, and technological advancements, which are expected to drive innovation and growth in the market during the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Roche Diagnostics; Siemens Healthcare GmbH; SQI Diagnostics; Bio-Rad Laboratories Inc.; Omega Diagnostics Group PLC; Beckton Dickinson & Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market is witnessing significant growth, driven by increasing demand for accurate and efficient diagnostic tests. The market dynamics are influenced by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in In Vitro Diagnostics (IVD) technology, such as next-generation sequencing and biomarker discovery, are driving the growth of the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market size

Growing prevalence of autoimmune diseases, such as rheumatoid arthritis and lupus, is fueling the demand for In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market, leading to a positive growth forecast

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market

Reimbursement challenges and pricing pressures are affecting the profitability of existing players, thereby hindering the growth forecast of the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market size

Opportunities2 items

Emerging economies, such as Asia Pacific and Latin America, offer significant opportunities for growth in the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market, driven by increasing healthcare expenditure and improving infrastructure

The trend towards personalized medicine and point-of-care testing is creating new avenues for In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market players to develop innovative and patient-centric diagnostic solutions

Challenges2 items

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market is facing challenges related to data privacy and cybersecurity, particularly with the increasing use of digital platforms and electronic health records

The market is also experiencing challenges in terms of standardization and harmonization of diagnostic tests, which can affect the accuracy and reliability of test results, ultimately impacting the growth forecast of the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market size

Market Segmentation

Loading chart…

The Application segment in the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market refers to the various uses of IVD and laboratory developed tests in diagnosing and monitoring autoimmune diseases. This segment is crucial in understanding the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases segmentation and its impact on the overall market size. The application segment includes subtypes such as diagnostic testing, monitoring, and research applications, each contributing to the growth of the market. Diagnostic testing is the largest application segment, as it enables healthcare professionals to diagnose autoimmune diseases accurately and promptly.

The Types segment in the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market encompasses various types of tests used to diagnose and monitor autoimmune diseases. This segment is vital in understanding the market taxonomy of IVD and laboratory developed tests. The types segment includes subtypes such as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), and Western blot, among others. ELISA is the most widely used type of test, due to its high sensitivity and specificity in detecting autoimmune diseases. Understanding the different types of tests and their applications is essential in determining the overall market size and growth prospects.

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Segmentation Breakdown14 items

Application

Diabetes

Infectious Diseases

Oncology or Cancer

Cardiology

Nephrology

Autoimmune Diseases

Drug Testing

HIV or Aids

Types

Reagents and Kits

Instruments

Services

Data Management Software

Regional Insights

Loading chart…

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market growth is expected to vary by region, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics such as an aging population and high prevalence of autoimmune diseases; for Europe, ecosystem maturity with well-established healthcare systems and a strong presence of major IVD manufacturers; for Asia Pacific, infrastructure development and government initiatives to improve healthcare access; for Latin America, growing awareness of autoimmune diseases and increasing demand for diagnostic tests; and for Middle East & Africa, partnerships between local healthcare providers and international IVD companies.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by expanding healthcare coverage and rising healthcare expenditure. In contrast, Middle East & Africa is expected to have a relatively lower growth rate due to limited infrastructure and regulatory challenges. Understanding these regional dynamics is crucial for stakeholders to navigate the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market effectively.

Competitive Landscape

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases competitive landscape is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is characterized by high competition, with companies focusing on product innovation and strategic partnerships to gain a competitive edge. The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases key players are investing heavily in research and development to improve their product portfolios and expand their market share.

Companies in this market are adopting various strategies to differentiate themselves, including technological advancements, strong service models, and cost advantages. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on regional expansion, innovation pipeline, and local manufacturing. The following companies are examples of this trend:

Abbott: regional expansion

Roche Diagnostics: innovation pipeline

Siemens Healthcare GmbH: vertical integration

SQI Diagnostics: premium pricing

Bio-Rad Laboratories Inc.: OEM tie-ups

Omega Diagnostics Group PLC: local manufacturing

Key In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Companies7 items

Abbott

Roche Diagnostics

Siemens Healthcare GmbH

SQI Diagnostics

Bio-Rad Laboratories Inc.

Omega Diagnostics Group PLC

Beckton Dickinson & Company

Market Ecosystem

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of IVD products and laboratory developed tests, which are then used by end users to diagnose and monitor autoimmune diseases. The ecosystem involves a complex interplay of various participants, each playing a distinct role in the value chain analysis.

Raw material/component suppliers — providing raw materials

OEMs / manufacturers — developing IVD products

Technology providers — offering testing technologies

Distributors / channel partners — distributing IVD products

Service providers / after-sales — offering maintenance services

End users / buyers — utilizing IVD products

Regulators/standards bodies — setting testing standards

The flow of value in the ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact the adoption of IVD products and laboratory developed tests. Dependency risks, including input constraints and standards, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem may differ by region, with varying regulatory frameworks, reimbursement policies, and market dynamics influencing the adoption and use of IVD products and laboratory developed tests for autoimmune diseases.

Recent Industry Insights

The In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between major diagnostic companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also led to the expansion of product portfolios and strengthened market positions. Furthermore, several product and technology launches have improved diagnostic accuracy and efficiency. Regulatory changes, including updated guidelines for laboratory-developed tests, have also impacted the industry. A shift in consumer and enterprise trends towards personalized medicine has fueled demand for advanced diagnostic solutions. Additionally, funding rounds and expansions have enabled companies to invest in research and development, accelerating the growth of the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases market outlook. The market attractiveness is relatively high, driven by the increasing prevalence of autoimmune diseases and the growing demand for accurate diagnostic tests. The competitive intensity is moderate, with key players investing in research and development to improve test sensitivity and specificity.

The long-term outlook for this market is positive, with the innovation landscape expected to shift towards more advanced technologies, such as next-generation sequencing and artificial intelligence. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and reimbursement pressures. Overall, the market is expected to experience steady growth, driven by the need for accurate and reliable diagnostic tests for autoimmune diseases.

11 items

1. Executive Summary

2. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diabetes

6.1.2. Infectious Diseases

6.1.3. Oncology or Cancer

6.1.4. Cardiology

6.1.5. Nephrology

6.1.6. Autoimmune Diseases

6.1.7. Drug Testing

6.1.8. HIV or Aids

6.2. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Reagents and Kits

6.2.2. Instruments

6.2.3. Services

6.2.4. Data Management Software

6.3. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Competition by Key Manufacturers

8.1. Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Roche Diagnostics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens Healthcare GmbH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. SQI Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Rad Laboratories Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Omega Diagnostics Group PLC

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Beckton Dickinson & Company

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market

Figure 4: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Drivers

Figure 5: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Challenges

Figure 6: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Trends

Figure 7: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Opportunity

Figure 8: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Restraint

Figure 9: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Value (USD Million) By Region

Figure 15: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Value (USD Million) By Region

Figure 23: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Value (USD Million) By Region

Table 10: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Roche Diagnostics Basic Information And Sales Area

Table 33: Roche Diagnostics. Products Portfolio

Table 34: Siemens Healthcare GmbH Basic Information And Sales Area

Table 35: Siemens Healthcare GmbH. Products Portfolio

Table 36: SQI Diagnostics Basic Information And Sales Area

Table 37: SQI Diagnostics. Products Portfolio

Table 38: Bio-Rad Laboratories Inc. Basic Information And Sales Area

Table 39: Bio-Rad Laboratories Inc.. Products Portfolio

Table 40: Omega Diagnostics Group PLC Basic Information And Sales Area

Table 41: Omega Diagnostics Group PLC. Products Portfolio

Table 42: Beckton Dickinson & Company Basic Information And Sales Area

Table 43: Beckton Dickinson & Company. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Value (USD Million) By Region

Table 49: Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	26.85 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Roche Diagnostics; Siemens Healthcare GmbH; SQI Diagnostics; Bio-Rad Laboratories Inc.; Omega Diagnostics Group PLC; Beckton Dickinson & Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options